[1] |
LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan.
Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
|
[2] |
WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua.
Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
|
[3] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[4] |
BAO Lei, GENG Zihan, CUI Xiaolan.
Therapeutic Effect of Shufeng Jiedu Capsules against Respiratory Syncytial Virus-Infected Pneumonia by Regulating AIM2 Inflammasome Pathway
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 495-500.
|
[5] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[6] |
FU Xiaoyan, GOU Yu, LUO Xianhai, HU Qiaozhi.
One Case of Anaphylactic Shock Caused by Multiple Oral Cephalexin Capsules Combined with Oolong Tea
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 341-342.
|
[7] |
BU Zhijun, LIU Fang, HOU Wenbin, SU Juanping, LIU Yandi, SU Xiaolan, WANG Jianyun, LI Junxiang, SUN Yuxin, CHEN Yunru, ZHENG Youyou, WANG Xuehui, LIU Fengshuang, TIAN Yuanchun, LIU Jianping, LIU Zhaolan.
Acceptance of Traditional Chinese Medicines in Patients with Ulcerative Colitis: a Multicenter Cross-Sectional Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 183-187.
|
[8] |
HU Yaping, ZHANG Aiwu.
One Case of Acute Drug-Induced Liver Injury Caused by Tingli Jiangxuezhi Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 224-226.
|
[9] |
WANG Yan, TENG Jingjing, YANG Tongjin, XIA Xin, YU Dandan, ZHAN Haibing, YANG Wenming.
Chronic toxicity study of Zhinao capsules in SD rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 878-883.
|
[10] |
PAN Zhiyu, ZHU Jian, YU Yanan, LIU Jun, JIANG Yanhua, QIAN Zhenzhen, WU Guang, WANG Zhong, WU Hongli, JING Zhiwei.
A real-world safety study of 3 010 cases of Qizhitongluo capsule
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 660-665.
|
[11] |
LIU Wenjie, GAO Yuanyuan, BAI Xue.
Advancements in Treating Ischemic Stroke with Chinese Medicine Compounds Formulae
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1382-1387.
|
[12] |
SONG Fuyu, CAO Yi.
Establishment of Key Performance Indicators for Drug Inspection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1411-1414.
|
[13] |
CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan.
Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50.
|
[14] |
LIU Qian, HU Jing, LI Bo, YANG Xiaojing.
Jinghuaweikang capsules combined with quadruple therapy in the treatment of Helicobacter pylori associated gastritis: a systematic evaluation and meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1039-1045.
|
[15] |
ZHU Chunwu, YU Xuejun, SUN Xin, LIU Chenghai.
Overview of hepatotoxicity of Xianling Gubao capsules
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 496-499.
|